Introduction

This page provides a comprehensive analysis of the known insider trading history of Peter C Wendell. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Peter C Wendell has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MRK / Merck & Co., Inc. Director 111,461
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Peter C Wendell. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Peter C Wendell as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-04-01 2022-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 366 111,461 0.33 82.05 30,000 9,145,350
2022-01-04 2021-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 391 110,152 0.36 76.64 30,000 8,442,043
2021-10-01 2021-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 399 108,900 0.37 75.11 30,000 8,179,462
2021-07-02 2021-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 386 107,613 0.36 77.77 30,000 8,369,077
2021-06-02 2021-05-28 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,635 104,036 2.60 75.89 200,000 7,895,284
2021-04-01 2021-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 389 100,545 0.39 77.09 30,000 7,751,033
2021-01-05 2020-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 367 99,381 0.37 81.80 30,000 8,129,363
2020-10-02 2020-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 362 98,268 0.37 82.95 30,000 8,151,335
2020-07-02 2020-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 388 97,157 0.40 77.33 30,000 7,513,114
2020-06-02 2020-05-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,478 96,769 2.63 80.72 200,000 7,811,160
2020-04-02 2020-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 390 93,567 0.42 76.94 30,000 7,199,074
2020-01-03 2019-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 316 92,542 0.34 90.95 28,750 8,416,740
2019-10-02 2019-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 342 91,631 0.37 84.18 28,750 7,713,533
2019-07-02 2019-06-28 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 343 90,699 0.38 83.85 28,750 7,605,074
2019-06-04 2019-05-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,336 90,356 2.65 79.21 185,000 7,157,073
2019-04-02 2019-03-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 346 87,430 0.40 83.17 28,750 7,271,545
2019-01-03 2018-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 376 86,461 0.44 76.41 28,750 6,606,497
2018-10-02 2018-09-28 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 405 85,510 0.48 70.94 28,750 6,066,064
2018-07-02 2018-06-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 474 84,455 0.56 60.70 28,750 5,126,391
2018-05-29 2018-05-25 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 3,131 83,981 3.87 59.09 185,000 4,962,432
2018-04-03 2018-04-02 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 540 80,134 0.68 53.27 28,750 4,268,743
2018-01-03 2017-12-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 489 78,930 0.62 56.27 27,500 4,441,384
2017-10-02 2017-09-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 429 77,877 0.55 64.03 27,500 4,986,480
2017-07-05 2017-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 429 76,876 0.56 64.09 27,500 4,926,976
2017-05-30 2017-05-26 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,619 76,447 3.55 64.92 170,000 4,962,927
2017-04-04 2017-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 433 73,286 0.59 63.54 27,500 4,656,581
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -15,000 1,000 -93.75 63.69 -955,406 63,694
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 16,000 45.45 24.30 121,500 388,800
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 11,000 83.33 35.19 175,950 387,090
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 6,000 500.00 38.04 190,200 228,240
2017-01-03 2016-12-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 467 72,300 0.65 58.87 27,500 4,256,328
2016-11-02 2016-11-02 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2016-11-02 2016-11-02 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -5,000 1,000 -83.33 59.50 -297,500 59,500
2016-11-02 2016-11-02 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 6,000 500.00 51.86 259,300 311,160
2016-10-04 2016-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 441 71,314 0.62 62.41 27,500 4,450,703
2016-07-01 2016-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 477 70,332 0.68 57.61 27,500 4,051,820
2016-05-31 2016-05-27 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 3,010 69,855 4.50 56.48 170,000 3,945,385
2016-04-04 2016-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 520 66,299 0.79 52.91 27,500 3,507,861
2016-01-04 2015-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 473 65,196 0.73 52.82 25,000 3,443,655
2015-10-28 2015-10-28 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2015-10-28 2015-10-28 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -5,000 1,000 -83.33 54.85 -274,237 54,847
2015-10-28 2015-10-28 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 6,000 500.00 34.44 172,200 206,640
2015-10-01 2015-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 506 64,161 0.80 49.39 25,000 3,168,888
2015-07-01 2015-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 439 63,162 0.70 56.93 25,000 3,595,823
2015-06-01 2015-05-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,463 62,723 4.09 60.89 150,000 3,819,207
2015-04-01 2015-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 435 59,792 0.73 57.48 25,000 3,436,856
2015-02-09 2015-02-09 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2015-02-09 2015-02-09 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -5,000 1,000 -83.33 58.76 -293,797 58,759
2015-02-09 2015-02-09 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 6,000 500.00 33.83 169,150 202,980
2015-01-02 2014-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 440 58,938 0.75 56.79 25,000 3,347,114
2014-10-02 2014-09-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 422 58,064 0.73 59.28 25,000 3,442,056
2014-07-01 2014-06-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 432 57,213 0.76 57.85 25,000 3,309,781
2014-06-03 2014-05-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 2,592 56,781 4.78 57.86 150,000 3,285,349
2014-04-02 2014-03-31 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 440 53,763 0.83 56.77 25,000 3,052,149
2014-02-11 2014-02-10 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2014-02-11 2014-02-10 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -5,000 1,000 -83.33 54.44 -272,193 54,439
2014-02-11 2014-02-10 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 6,000 500.00 47.23 236,150 283,380
2014-01-02 2013-12-31 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 500 52,860 0.95 50.05 25,000 2,645,659
2013-10-02 2013-09-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 525 51,900 1.02 47.61 25,000 2,470,937
2013-07-01 2013-06-28 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 538 50,917 1.07 46.45 25,000 2,365,118
2013-06-03 2013-05-31 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 3,212 50,379 6.81 46.70 150,000 2,352,713
2013-04-01 2013-03-28 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 566 46,727 1.23 44.20 25,000 2,065,354
2013-01-03 2012-12-31 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 611 45,702 1.35 40.94 25,000 1,871,047
2012-11-13 2012-11-09 4 MRK Merck & Co. Inc.
Common Stock
G - Gift -1,500 1,000 -60.00
2012-10-01 2012-09-28 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 554 44,691 1.26 45.10 25,000 2,015,560
2012-07-02 2012-06-29 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 599 43,707 1.39 41.75 25,000 1,824,761
2012-05-29 2012-05-25 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 3,995 43,108 10.21 37.55 150,000 1,618,707
2012-04-03 2012-03-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 651 38,701 1.71 38.40 25,000 1,486,108
2012-01-04 2011-12-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 663 37,645 1.79 37.70 25,000 1,419,220
2010-08-06 2010-08-04 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 5,000 5,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)